Kaylite Cream is a topical formulation combining Hydroquinone (2% w/w), Mometasone furoate (0.1% w/w), and Tretinoin (0.025% w/w), designed for the treatment of hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, and other pigmentary abnormalities. Hydroquinone acts as a skin-lightening agent by inhibiting tyrosinase, an enzyme crucial for melanin synthesis, thereby reducing excessive pigmentation. Mometasone furoate, a potent corticosteroid, provides anti-inflammatory and immunosuppressive effects, helping to reduce erythema, swelling, and irritation associated with pigmentary conditions. Tretinoin, a retinoid, promotes epidermal cell turnover and enhances the penetration of hydroquinone, facilitating more effective pigment reduction and skin renewal. The combination therapy aims to achieve a synergistic effect, improving skin tone and texture while minimizing inflammation. Kaylite Cream should be applied once daily to the affected areas as directed by a healthcare professional. Caution is advised due to potential side effects such as skin irritation, dryness, and photosensitivity; therefore, concurrent use of sunscreen and avoidance of excessive sun exposure are recommended. This product is intended for short-term use under medical supervision to prevent adverse effects associated with prolonged corticosteroid and retinoid application.